Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. NovaBay Pharmaceuticals Inc New (NBY)

  7. NovaBay Pharmaceuticals Inc New (NBY) News

NBY

NovaBay Pharmaceuticals Inc New

0.6102
0.0101 (1.68%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
NovaBay Pharmaceuticals Inc New NBY AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.0101 1.68% 0.6102 15:43:39
Open Price Low Price High Price Close Price Prev Close
0.61 0.61 0.638 0.6001
more quote information »

Recent News

Date Time Source Heading
5/31/202316:32EDGARSecurities Registration Statement (s-1)
5/31/202316:17EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
5/31/202316:16EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
5/23/202306:01EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
5/18/202317:20EDGARSmall Company Offering and Sale of Securities Without..
5/18/202307:19EDGARAnnual Report to Security Holders (ars)
5/18/202307:01EDGARProxy Statement (definitive) (def 14a)
5/17/202316:16EDGARSecurities Registration Statement (s-1/a)
5/15/202318:55EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202318:55EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202318:54EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202318:54EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202318:53EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202318:53EDGARStatement of Changes in Beneficial Ownership (4)
5/11/202316:05BWNovaBay Pharmaceuticals Reports First Quarter 2023 Financial..
5/05/202306:50BWPhaseOne Health Collaborates with Nonprofit Humanitarian..
5/04/202308:10EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/04/202306:50BWNovaBay Pharmaceuticals to Hold First Quarter 2023..
5/02/202308:01EDGARCurrent Report Filing (8-k)
5/01/202306:50BWNovaBay Pharmaceuticals Fulfills $1 Million Order for..
4/27/202316:47BWNovaBay Pharmaceuticals Announces $3.0 Million Convertible..
4/21/202306:50BWNovaBay Pharmaceuticals Launches DERMAdoctor’s New Comfort +..
3/31/202317:32EDGARSecurities Registration Statement (s-1/a)
3/31/202316:22EDGARAnnual Report (10-k)
3/30/202316:06BWNovaBay Pharmaceuticals Reports 2022 Fourth Quarter and Full..
3/23/202306:50BWNovaBay Pharmaceuticals to Hold 2022 Fourth Quarter and Full..
3/14/202306:50BWEyeganics Organic Tears, the Only USDA-Certified Organic..
3/07/202306:50BWNovaBay Pharmaceuticals Launches Avenova® Eye Health..
2/24/202316:52EDGARInitial Statement of Beneficial Ownership (3)
2/14/202313:12EDGARStatement of Ownership (sc 13g)
2/10/202315:04EDGARAmended Statement of Ownership (sc 13g/a)
2/06/202306:50BWNovaBay Pharmaceuticals Chief Product Officer Dr. Audrey..
1/31/202306:50BWNovaBay Pharmaceuticals to Present at the Virtual Sequire..
1/20/202317:08EDGARCurrent Report Filing (8-k)
1/17/202306:50BWPhaseOne Health and NovaBay Pharmaceuticals to Expand..
12/30/202216:17EDGARSecurities Registration Statement (s-1)
12/16/202207:01EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
12/09/202216:59EDGARSecurities Registration Statement (s-1)
11/29/202206:50BWNovaBay Pharmaceuticals Announces the Launch of..
11/23/202216:17EDGARStatement of Changes in Beneficial Ownership (4)
11/23/202216:16EDGARStatement of Changes in Beneficial Ownership (4)
11/18/202216:58EDGARCurrent Report Filing (8-k)
11/17/202206:50BWNovaBay Pharmaceuticals Chief Product Officer Dr. Audrey..
11/14/202216:51EDGARCurrent Report Filing (8-k)
11/14/202216:31EDGARQuarterly Report (10-q)
11/14/202216:05BWNovaBay Pharmaceuticals Reports Third Quarter 2022 Financial..
11/14/202216:02BWNovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock..
11/09/202216:05BWNovaBay Pharmaceuticals to Hold Third Quarter 2022..
11/01/202216:17EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
10/26/202206:50BWNovaBay Pharmaceuticals Announces Expansion of DERMAdoctor..